Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.

We conducted a randomized controlled trial of orally administered amifloxacin versus trimethoprimsulfamethoxazole (TMP-SMX) as treatments of acute uncomplicated urinary tract infection in women. Amifloxacin at a dosage of 200 mg twice a day appeared as safe and effective as TMP-SMX, but amifloxacin...

詳細記述

保存先:

書誌詳細
出版年:	Antimicrob Agents Chemother
主要な著者:	Boyko, E J, Iravani, A, Silverman, M H, Schelling, D J, Wright, R A
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1990
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171664/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2188590/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.4.665
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.

類似資料